Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

17 Jul 2012 10:31

RNS Number : 8307H
Ubisense Group PLC
17 July 2012
 



 

17 July 2012

 

 

Ubisense Group plc

 

("Ubisense" or "the Company") 

 

Grant of Options 

 

Ubisense Group plc (AIM: UBI) announces that on 29 June 2012 the Board approved the grant of 347,000 options over ordinary shares of £0.02 each in the Company ("Ordinary Shares") to certain directors and key employees of the Company ("Share Options").

 

The Share Options granted to directors are as follows:

 

Richard Green

60,000

Gordon Campbell

40,000

 

The Share Options are to subscribe for new ordinary shares in the Company and the exercise price is 212.50 pence per ordinary share, being the closing price of the Ordinary Shares on 28 June 2012.

 

For the directors, one third of the Share Options will vest on the first anniversary of the date of grant with the balance vesting in equal tranches on the second and third anniversaries. The grants will be fully vested on the third anniversary of the date of grant. The grants vest subject to meeting performance criteria set out in the long-term incentive plan ("LTIP"). The grants to employees are not subject to performance criteria and vest fully on the third anniversary of the date of grant. All share options must be exercised on or before 29 June 2022, failing which they will lapse.

 

After granting the above share options the beneficial and other interests of the directors and their families in the shares of the Company at 16 July 2012 are:

 

Ordinary Shares

% of Issued Share Capital

Options Over Ordinary Shares

Robert Sansom

2,493,676

11.44

-

Richard Green

1,543,011

7.08

236,278

Richard Newell

643,354

2.95

1,056

Andrew Hopper

225,000

1.03

20,278

Gordon Campbell

87,987

0.40

193,000

Peter Harverson

65,161

0.30

91,333

J Keith Lomas

47,712

0.22

-

Paul Taylor

-

-

-

 

Following the grant of the above options, the share capital of the Company comprises 21,804,967 Ordinary Shares, with voting rights, plus 2,090,720 options over Ordinary Shares.

 

The above figure of 21,804,967 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the DTR.

 

For further information, see the Company's website www.ubisense.net or contact one of the following:

 

 

Enquiries:

 

Ubisense Group Plc

Tel: +44 (0) 1223 535 170

Richard Green 

Gordon Campbell

Canaccord Genuity Limited (NOMAD)

Tel: +44 (0) 20 7523 8000

Simon Bridges

Kit Stephenson 

FTI Consulting

Tel: +44 (0) 20 7831 3113

James Melville-Ross

Jon Snowball

 

 

About Ubisense:

 

Ubisense, a market leader in location solution technology, delivers mission-critical enterprise asset tracking and geospatial systems. The company's location technology provides more than 500 customers worldwide with unprecedented visibility of, and control over, previously intractable business processes. Ubisense is headquartered in Cambridge, UK, with offices in the USA; Canada; France; Germany; Singapore; and Korea. For more information visit: www.ubisense.net

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFFADAIDLIF
Date   Source Headline
23rd Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSInvestor Presentation
29th Jan 20217:00 amRNSContract Win
18th Jan 202111:10 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSTrading Update
6th Jan 202110:57 amRNSDirector/PDMR Shareholding
31st Dec 202012:00 pmRNSBlock listing Interim Review
31st Dec 20207:00 amRNSDisposal of Minority Interest
22nd Dec 20205:14 pmRNSHolding(s) in Company
22nd Dec 20203:46 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSContract Win
21st Dec 20208:30 amRNSCompletion of Fundraising, Acquisition & TVR
18th Dec 20205:15 pmRNSInitial Consideration Shares
18th Dec 202010:51 amRNSResult of General Meeting
8th Dec 20203:52 pmRNSHolding(s) in Company
3rd Dec 20207:00 amRNSGrant of Options
1st Dec 20202:50 pmRNSResults of Fundraising
1st Dec 20208:45 amRNSProposed Acquisition and Fundraising
28th Oct 20203:53 pmRNSChange of Registered Office
19th Oct 20207:00 amRNSIQGeo announces major contract extension
14th Sep 20207:00 amRNSInterim Results 1H 2020
7th Sep 20207:00 amRNSInvestor Presentation
3rd Sep 20207:00 amRNSIQGeo announces major new telecoms customer in USA
4th Aug 20207:00 amRNSDirectorate Change
20th Jul 20201:55 pmRNSDirectors' Dealings
14th Jul 20207:00 amRNSIQGeo Trading Update
2nd Jul 20207:00 amRNSBlock Listing Six Monthly Return
30th Jun 20207:00 amRNSIQGeo announces major contract expansion
29th Jun 202012:09 pmRNSDirectors' Dealings
15th Jun 20203:33 pmRNSResults of Annual General Meeting
8th Jun 20209:39 amRNSDirectors' Dealings
26th May 20207:00 amRNSDirectors' Dealings
21st May 20207:00 amRNSPosting of the Notice of Annual General Meeting
18th May 20203:29 pmRNSDirectors’ Dealings
13th May 20203:30 pmRNSDirector's Dealings
15th Apr 20209:27 amRNSDirector's Dealings
7th Apr 20207:00 amRNSPosting of Annual Financial Report
1st Apr 20204:18 pmRNSDirector's Dealings
30th Mar 20206:01 pmRNSDirector's Dealings
26th Mar 20207:00 amRNSTEPCO major contract expansion and COVID-19 update
24th Mar 20208:08 amRNSDirectors' Dealing
17th Mar 20204:26 pmRNSDirector's dealings
17th Mar 20204:21 pmRNSTR1 notification of major holdings
13th Mar 202010:55 amRNSDirectors' Dealings
11th Mar 20201:43 pmRNSDirector's Dealings
9th Mar 20207:00 amRNSAnnual Financial Report
3rd Feb 20202:59 pmRNSDirector's Dealing and Total Voting Rights
28th Jan 20207:00 amRNSTrading update
9th Jan 20204:30 pmRNSDirectors' dealings
2nd Jan 20205:16 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.